Search
for
Sort by
Research 30 of 63
- Refractory dissecting cellulitis of the scalp treated with risankizumab: 2 case reports
- 44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
- 43364 Long Term Real-World Patient-Reported Outcomes with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
- Off-label dermatologic uses of IL-23 inhibitors
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- S4890 Infliximab-Induced Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis Syndrome
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge
- What causes hidradenitis suppurativa ?—15 years after
- The role of diet in the management of psoriasis: a scoping review
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Olink proteomics analysis of scalp psoriasis reveals a cytokine storm inflammatory mainly related to bacterial-derived antigens
- Advances in dermatology research: A comprehensive literature review
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- Latest Advances in Inflammatory Skin Disease
- Drug pipeline 2Q22 — a downturn in approvals
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- 0282 Effect of systemic immunomodulators on incidence of alopecia areata: A retrospective cohort study
- Editor's Picks
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment